David J Lloyd

Title: David J Lloyd: Innovator in Metabolic Disorder Treatments

Introduction

David J Lloyd is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of metabolic disorder treatments, holding a total of 6 patents. His work focuses on innovative methods to address various metabolic diseases, including type 2 diabetes and obesity.

Latest Patents

David's latest patents include groundbreaking methods for treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR) and GLP-1 receptor agonist fusion proteins. These methods provide compositions that target metabolic diseases and disorders, specifically type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic nephropathy. One notable patent describes a composition that comprises the C-terminus of a GLP-1 analog fused to the N-terminus of an antibody's variable region that binds GIPR, potentially with a linker in between. Another patent outlines methods of treating metabolic diseases using an antigen binding protein specific for the GIPR polypeptide, administered in combination with GLP-1 receptor agonists.

Career Highlights

Throughout his career, David has worked with notable companies, including Amgen Inc. His expertise in the field has led to significant advancements in the treatment of metabolic disorders.

Collaborations

David has collaborated with esteemed colleagues, including Donghui Shi and Darren L Bates, contributing to the development of innovative solutions in metabolic health.

Conclusion

David J Lloyd's contributions to the field of metabolic disorder treatments through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in the treatment of metabolic diseases.